Format

Send to:

Choose Destination
See comment in PubMed Commons below
Hosp Pharm. 2014 Apr;49(4):345-7. doi: 10.1310/hpj4904-354.

Topiramate: antipsychotic-induced weight gain.

Author information

  • 1Editor-in-Chief, Hospital Pharmacy, and Clinical Professor, Emeritus, Department of Pharmacy Practice, University of Kansas, School of Pharmacy , Kansas City/Lawrence , Kansas , e-mail: jgeneral@ku.edu.
  • 2Founder and Contributing Editor, The Formulary, and Editor, Off-Label Drug Facts , e-mail: Dennis.Cada@wolterskluwer.com .

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

PMID:
24958940
[PubMed]
PMCID:
PMC4062746
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk